pharmaphorum

DECEMBER 29, 2020

NHS England’s chief executive Sir Simon Stevens has said that all vulnerable people over the age of 50 will be offered a COVID-19 vaccine by “late spring” in a message to healthcare workers. The prediction comes after the NHS announced on Christmas Eve that more than half a million people had received the Pfizer/BioNTech shot approved in early December, but will depend on additional vaccine supplies coming “on stream”, according to Stevens.

Vaccination 105

Vaccination Vaccine Trials Protein 105

BioSpace

DECEMBER 29, 2020

Operation Warp Speed succeeded on the development component, but is failing in the early stages of distribution.

Vaccination 130

Vaccination Vaccine Development 130

Pharma Marketing Network

DECEMBER 29, 2020

2020 was a year defined by unexpected challenges – and related opportunity – for pharmaceutical marketers. The COVID-19 pandemic pushed the industry to experiment with new media, emerging technologies and innovative platforms to keep physicians, providers and patients informed, engaged and empowered. As telehealth appointments replaced office visits, webinars replaced in-person conferences and digital communication replaced reps in the field, what have we learned about how to create connec

Branding 98

Branding Marketing 98

Scienmag

DECEMBER 29, 2020

Observational clinical research of COVID-19 patients can help clinicians better understand how the previously unknown SARS-CoV-2 virus acts, and findings from this research can better inform treatment and vaccine design. Credit: UAB BIRMINGHAM, Ala. – COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path. Many infected patients remain asymptomatic or […].

Clinical Research 87

Clinical Research Vaccination Vaccine Research 87

Advertisement

Clinical Supply

BioSpace

DECEMBER 29, 2020

A great deal remains unknown about the SARS-CoV-2 virus, its mutations, transmissibility and long-term effects. Here’s what we do know.

Vaccination 100

Vaccination Vaccine 100

Scienmag

DECEMBER 29, 2020

One of the physiopathological characteristics of COVID-19 that has most baffled the scientific and medical community is what is known as “silent hypoxemia” or “happy hypoxia” Patients suffering this phenomenon, the causes of which are still unknown, have severe pneumonia with markedly decreased arterial blood oxygen levels (known as hypoxemia).

Medicine 60

Medicine 60

The Pharma Data

DECEMBER 29, 2020

. HOUSTON , Dec. 30, 2020 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology, today announced the appointment of Sean J. Shapiro as Vice President of Sales, effective January 1, 2021. Brad Hauser , Soliton’s President and CEO, commented, “We are very excited to have Sean join our team during this pivotal time for th

Sales 52

Sales Containment Production Licensing 52

BioSpace

DECEMBER 29, 2020

Overnight, U.K. health authorities authorized the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use.

Vaccination 96

Vaccination Vaccine Development 96

The Pharma Data

DECEMBER 29, 2020

The addressable market is estimated to be $80M CDN by 2022. Tetra meets another key milestone before the end of the year. OTTAWA, ON / ACCESSWIRE / December 30, 2020 / Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) ( TSX:TBP )( OTCQB:TBPMF ), a leader in cannabinoid-derived drug discovery and development announced today that the New Drug Submission (NDS) for the Dronabinol Soft Gel capsules, has been filed with Health Canada.

Drugs 52

Drugs Regulation Marketing Production 52

BioSpace

DECEMBER 29, 2020

Fabry disease is a rare, X-linked inherited disease that results from abnormal deposits of a fatty substance in blood vessels.

97

97

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

The Pharma Data

DECEMBER 29, 2020

Dec. 30, 2020 11:00 UTC. Insights from Optimity app user survey finds that 43% believe the COVID-19 vaccine should be mandatory, while 53% believe that Canadians should have a choice of which vaccine to receive. TORONTO–( BUSINESS WIRE )– Optimity Inc. , a mission-driven technology company focused on improving population health, today unveiled results from the 2020 COVID-19 Vaccine Survey of Optimity app users.

Vaccination 52

Vaccination Vaccine Manufacturing Branding 52

BioSpace

DECEMBER 29, 2020

Keeping in mind that COVID-19 has dominated the news cycle, here are the top 10 stories of 2020 in no particular order.

88

88

The Pharma Data

DECEMBER 29, 2020

SUZHOU, China and ROCKVILLE, Md., Dec. 30, 2020 /PRNewswire/ — Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company was officially included into the Shenzhen-Hong Kong Stock Connect program (the “Hong Kong Stock Connect”).

Drugs 52

Drugs Development Protein Clinical Development 52

Scienmag

DECEMBER 29, 2020

Insilico enters into a collaboration with APRINOIA to apply novel generative AI-powered system to discover novel compounds for neurodegenerative diseases Credit: Insilico Wednesday, 30th of December, 2020 (9:00AM, Taipei) – Insilico Medicine is pleased to announce that it has entered into a research collaboration with APRINOIA Therapeutics to utilize Insilico’s novel generative artificial intelligence (AI) […].

Medicine 52

Medicine Drugs Research Bioinformatics 52

Advertisement

Clinical Supply

The Pharma Data

DECEMBER 29, 2020

News. Professional. FDA Authorizes Marketing of EndoRotor System. TUESDAY, Dec. 29, 2020 — The U.S. Food and Drug Administration granted marketing authorization to the EndoRotor System, which provides a minimally invasive way to resect and remove necrotic tissue for patients with walled-off pancreatic necrosis (WOPN), the agency announced last week.

Marketing 52

Marketing Trials Development Drugs 52

BioTech 365

DECEMBER 29, 2020

Oragenics Announces Closing of $6.5 Million Registered Direct Offering Oragenics Announces Closing of $6.5 Million Registered Direct Offering TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc.

Vaccination 52

Vaccination Vaccine 52

The Pharma Data

DECEMBER 29, 2020

Dec. 30, 2020 01:00 UTC. TORONTO–( BUSINESS WIRE )– Cybin Inc. ( NEO:CYBN ) (“ Cybin ”), a life sciences company focused on psychedelic pharmaceutical therapies, announces the unaudited financial results of Clarmin Explorations Inc. (now Cybin Inc.) for the three month period ended October 31, 2020. A copy of the unaudited consolidated financial statements prepared in accordance with International Financial Reporting Standards and the corresponding management’s discussion and analysi

Life Science 52

Life Science Bioavailability Containment Clinical Trials 52

Scienmag

DECEMBER 29, 2020

Credit: FEFU press office Carrageenans, biologically active polysaccharides isolated from red algae and widely used in the food industry as stabilizers, thickeners, or jelly agents have an express effect on the immune systems of mice, a study reports. The research was carried out by scientists from the School of Biomedicine of Far Eastern Federal University […].

Scientist 52

Scientist Research Engineer Medicine 52

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

The Pharma Data

DECEMBER 29, 2020

News. Professional. One in Four Older Adults Have Used Emergency Dept in Past Few Years. TUESDAY, Dec. 29, 2020 — Older adults often use the emergency department when they cannot get timely outpatient appointments, according to a report published online Dec. 15 based on the results of the University of Michigan National Poll on Healthy Aging. Preeti Malani, M.D., from the University of Michigan Institute for Healthcare Policy and Innovation in Ann Arbor, and colleagues surveyed a national

52

52

Scienmag

DECEMBER 29, 2020

Credit: Rotman School of Management Toronto – With the arrival of effective vaccines for the COVID-19 virus, the end of the pandemic is on the horizon but in the short term the virus continues to spread. A timely new study published today by PLOS ONE examines the effectiveness of COVID-19 control policies in 40 jurisdictions […].

Vaccination 52

Vaccination Vaccine Medicine 52

The Pharma Data

DECEMBER 29, 2020

News. Professional. Seizure Frequency Not Up in Pregnancy for Women With Epilepsy. TUESDAY, Dec. 29, 2020 — Among women with epilepsy, the percentage who have a higher incidence of seizures during pregnancy than in the postpartum period is similar to that seen during corresponding epochs in women who are not pregnant, according to a study published in the Dec. 24 issue of the New England Journal of Medicine.

Medicine 52

Medicine Drugs Research 52

Scienmag

DECEMBER 29, 2020

Since patients with ballistic embedded fragments are frequently denied MRI, due to indeterminate bullet composition sans shell casings, radiography and CT can be used to identify nonferromagnetic projectiles that are safe for MRI Credit: American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR) Leesburg, VA, December 29, 2020–According to an article in ARRS’ American […].

Medicine 52

Medicine 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

The Pharma Data

DECEMBER 29, 2020

News. Professional. Knee Osteoarthritis Symptoms Improved With Stepped Care. TUESDAY, Dec. 29, 2020 — A stepped exercise program results in modest improvements for symptoms of knee osteoarthritis, according to a study published online Dec. 29 in the Annals of Internal Medicine. Kelli D. Allen, Ph.D., from the Durham VA Health Care System in North Carolina, and colleagues conducted a randomized controlled trial at two U.S.

Medicine 52

Medicine Trials Research 52

Scienmag

DECEMBER 29, 2020

Biotechnologists measure the forces with which algae cells adhere to surfaces and move on them Credit: Lara Hoepfner How can cells adhere to surfaces and move on them? This is a question which was investigated by an international team of researchers headed by Prof. Michael Hippler from the University of Münster and Prof. Kaiyao Huang […].

Research 52

Research 52

The Pharma Data

DECEMBER 29, 2020

News. Professional. Anticoagulants Not Tied to Higher Risk for GI Bleed in COVID-19. TUESDAY, Dec. 29, 2020 — Use of anticoagulation or antiplatelet agents is not a risk factor for gastrointestinal (GI) bleeding among hospitalized COVID-19 patients, according to a study published online Dec. 20 in the Journal of Internal Medicine. Arvind J. Trindade, M.D., from the Feinstein Institutes for Medical Research at Northwell Health in Manhasset, New York, and colleagues examined risk factors ass

Medicine 52

Medicine Research Development 52

Scienmag

DECEMBER 29, 2020

Credit: (Photo illustration / U.S. Army) ADELPHI, Md. — Multi-domain operations, the Army’s future operating concept, requires autonomous agents with learning components to operate alongside the warfighter. New Army research reduces the unpredictability of current training reinforcement learning policies so that they are more practically applicable to physical systems, especially ground robots.

Research 52

Research Engineer Development 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

The Pharma Data

DECEMBER 29, 2020

News. Professional. SARS-CoV-2 Reinfection Risk Drops With Presence of Antibodies. TUESDAY, Dec. 29, 2020 — Health care workers with anti-spike or anti-nucleocapsid immunoglobulin G (IgG) antibodies have a reduced risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in the following six months, according to a study published online Dec. 23 in the New England Journal of Medicine.

Antibody 52

Antibody Medicine Research 52

Scienmag

DECEMBER 29, 2020

Credit: Ralph Panstruga & Matthew Moscou People have puzzled for years why pathogen Phytophthora infestens causes the devastating late blight disease, source of the Irish Potato famine, on potatoes, but has no effect at all on plants like apple or cucumber. How are apple trees and cucumber plants able to completely shake off this devastating […].

Production 52

Production 52

The Pharma Data

DECEMBER 29, 2020

TUESDAY, Dec. 29, 2020 — Adults with attention-deficit/hyperactivity disorder (ADHD) have a strikingly high prevalence of attempted suicide, with women being at particular risk, researchers say. The study of nearly 22,000 Canadian adults found that 14% of those with ADHD had attempted suicide. That was roughly five times the rate of adults without ADHD, at 2.7%.

Research 52

Research Drugs 52

Scienmag

DECEMBER 29, 2020

Guidelines maintain existing serving size for whole and enriched grains Credit: The Grain Chain The Grain Chain, a farm to fork coalition of stakeholders in the grain industry sector and chaired by the American Bakers Association (ABA), celebrates the recommendation published today in the 2020-2025 Dietary Guidelines for Americans (DGAs) to “consume half of your […].

Medicine 52

Medicine 52

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Clinical Supply